Skip to content
Portage Biotech
Portage BiotechPortage Biotech
  • about us
    • overview
    • leadership
  • our pipeline
    • iNKT platform
    • adenosine platform
    • other programs in development
  • investors
    • overview
    • stock information
    • news releases
    • investor calendar
    • presentations & publications
    • sec filings
    • financial & regulatory reports
    • corporate governance
    • investor faqs
  • join our team
  • contact
  • about us
    • overview
    • leadership
  • our pipeline
    • iNKT platform
    • adenosine platform
    • other programs in development
  • investors
    • overview
    • stock information
    • news releases
    • investor calendar
    • presentations & publications
    • sec filings
    • financial & regulatory reports
    • corporate governance
    • investor faqs
  • join our team
  • contact

Daily Archives: February 24, 2016

Interim Financial Statement for Q3 Fiscal 2016

Financial and Regulatory ReportsBy Portage Biotech, IncFebruary 24, 2016
...

Management’s Discussion and Analysis Q3 Fiscal 2016

Financial and Regulatory ReportsBy Portage Biotech, IncFebruary 24, 2016
...

Portage’s Biohaven Announces Positive Results from Phase I Study with BHV-0223

Press ReleaseBy Portage Biotech, IncFebruary 24, 2016
...
Copyright © All rights reserved Portage Biotech, Inc

terms of use   privacy policy   disclaimer

Go to Top